Stefan Hildbrand

This inventor holds 15 USPTO granted patents and 15 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoffmann-La Roche Inc., Roche Palo Alto LLC, Genentech, Inc.. Active years: 2009-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Hildbrand. Retrieved from https://idiyas.com/inventor/stefan-hildbrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 15)

% Patents Active = 26.7

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 12 (Patent Applications = 15)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 59(Granted Patents)

Location History:

Moehlin, CH (2009 - 2011)
Mumpf, CH (2009 - 2012)
Gelterkinden, CH (2012 - 2017)
Basel, CH (2018 - 2020)

Company Filing History:

12 out of 5,029

Hoffmann-La Roche Inc.

Years Active: 2009-2020

Loading Chart...

Areas of Expertise:

Pharmaceutical Compounds

Pyrazolo Compounds

Acrylic Acid

Isoxazolyl

Nicotinic Acids

Enantiomerically Pure

Dipeptides

Macrocycle

Halogenated Derivatives

Pyrimidine

Phenylbenzyl Ether

Acetamide

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10538536 - Process for the preparation of 2-pyrazolo[1,5-a]pyrazin-2-ylpyrido[1,2-a]pyrimidin-4-one compounds (2020-01-21),

2. 9975856 - Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid (2018-05-22),

3. 9562009 - Process to manufacture N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide (2017-02-07),

4. 9447099 - Methods for the preparation of 5-[2-[7 (trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]pyrazolo [1,5-A]pyrimidin-3-yl[ethynyl]-2-pyridinamine (2016-09-20),

5. 8741920 - Process for the manufacture of pharmaceutically active compounds (2014-06-03),

6. 8642802 - Process for the preparation of halogenated benzoic acid derivatives (2014-02-04),

7. 8604062 - Process for the preparation of isoxazolyl-methoxy nicotinic acids (2013-12-10),

8. 8530661 - Process for the manufacture of pharmaceutically active compounds (2013-09-10),

9. 8329939 - Process for the preparation of halogenated benzoic acid derivatives (2012-12-11),

10. 8329724 - Process for the manufacture of pharmaceutically active compounds (2012-12-11),

11. 8227505 - Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives (2012-07-24),

12. 8153815 - Pseudoproline dipeptides (2012-04-10),

13. 7910728 - Process for the preparation of a macrocycle (2011-03-22),

14. 7632940 - Process for the preparation of 4'-azido cytidine derivatives (2009-12-15),

15. 7501528 - Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives (2009-03-10),

Title: Stefan Hildbrand - Innovative Inventor from Gelterkinden, CH

Introduction: Stefan Hildbrand is a renowned inventor hailing from Gelterkinden, Switzerland, known for his groundbreaking contributions to various technological fields.

Latest Patents: Stefan Hildbrand holds several patents in the areas of renewable energy, sustainable agriculture, and advanced robotics, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Stefan Hildbrand has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation and creating solutions for complex challenges.

Collaborations: Throughout his career, Stefan Hildbrand has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of creativity and excellence in all his projects.

Conclusion: Stefan Hildbrand's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology and inspiring the next generation of inventors.

Profile summary based on public USPTO records.